Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Jun 16 2023 | U.S. Food and Drug Administration Approves Addition of Positive Data from Phase 3 VALOR-HCM Study to CAMZYOS® (mavacamten) Label Industry News In The News Industry Read More Jun 16 2023 | Daxor Accelerates Blood Volume Analysis Adoption with the Launch of ezBVA Lab Services Industry News In The News Industry Read More Jun 11 2023 | HFSA President's Update: June 2023 HFSA News President's Updates Read More Jun 11 2023 | Members and Leaders of HFSA to be Recognized at the 2023 Annual Scientific Meeting in Cleveland, OH HFSA News Annual Scientific Meeting Awards Read More Jun 7 2023 | Free HFSA Membership for Trainees HFSA News Membership Read More Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Jun 16 2023 | U.S. Food and Drug Administration Approves Addition of Positive Data from Phase 3 VALOR-HCM Study to CAMZYOS® (mavacamten) Label Industry News In The News Industry Read More
Jun 16 2023 | Daxor Accelerates Blood Volume Analysis Adoption with the Launch of ezBVA Lab Services Industry News In The News Industry Read More
Jun 11 2023 | Members and Leaders of HFSA to be Recognized at the 2023 Annual Scientific Meeting in Cleveland, OH HFSA News Annual Scientific Meeting Awards Read More
